Skip to main content

Profile: Sai Sudha Koka

Placeholder
Sai Sudha Koka, Ph.D., R.Ph.
Research Assistant Professor of Pharmacology
Department of Pharmacological and Pharmaceutical Sciences
Physical Address: Science and Research Building 2, 3455 Cullen Blvd., Room 463, Houston, TX 77204
Mailing Address: Health and Biomedical Sciences Building 2, 4849 Calhoun Road, Room 3044, Houston, TX 77204-5037

713-743-1086 (Office)
sskoka@uh.edu

Education & Certifications

Ph.D. in Pharmacology and Toxicology, Eberhard Karls University of Tuebingen, Tuebingen, Germany

Masters of Pharmacy [Pharmacology], College of Pharmaceutical Sciences, Andhra University, India

Bachelors of Pharmacy, College of Pharmaceutical Sciences, Andhra University, India

Registered Pharmacist, Virginia Board of Pharmacy

Pharmacy-based Immunization Delivery, American Pharmacists Association

Research Interests

My research focuses on understanding the cellular and molecular mechanisms regulating the development of cardiometabolic disorders and identifying novel pharmacologic strategies to combat cardiovascular diseases such as atherosclerosis in diabetic, obese and aging patients.

Current research studies are focused on exploring the role of gut microbe-derived metabolites in endothelial and vascular cell signaling, inflammation and cardiovascular dysfunction.

Awards and Honors

  • American Radiolabeled Chemicals Junior Scientist Award in Pharmacology, 31st Annual meeting of ASIOA, 2013
  • Donna Garff Marriott Research Award, Women’s board of American Heart Association Greater Washington Region, 2012
  • Best Science Award for poster, Scientific Sessions 2012, American Heart Association, 2012
  • VCU Postdoctoral Association Travel Award to attend American Heart Association Scientific Sessions, 2012
  • Best Poster Award- VCU postdoctoral appreciation week poster competition-2012, VCU Postdoctoral Association, 2012
  • Young investigator Travel Award, Winnipeg Heart International Conference-2011, Institute of Cardiovascular Sciences, 2011
  • Best Poster Award - 9th Annual Meeting, National Postdoctoral Association, 2011
  • American Heart Association Mid-Atlantic affiliate Postdoctoral Fellowship, 2011
  • Travel Award from VCU Postdoctoral Association to attend American Heart Association Scientific Sessions, 2010
  • Recipient of the prestigious Summer Research Fellowship-2001 by Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India, 2001
  • Recipient of Dr. A.S. Rao Award in 5th Science talent search by Dr. A.S. Rao Awards Council at Hyderabad during 1992-93

Publications

Boini KM, Koka S, Xia M, Gehr TB, Ritter JK and Li PL. Sphingolipids in Obesity and its Complications. Frontiers in Bioscience (Land Mark edition), 22: 96-116, 2017.

Boini KM, Koka S, Xia M, Gehr TW, Li PL. Instigation of NLRP3 Inflammasome Activation and Glomerular Injury in Mice on the High Fat Diet: Role of Acid Sphingomyelinase Gene. Oncotarget, 7 (14): 19031-19044, 2016.

Xia M, Abais JM, Koka S, Meng N, Gehr TW, Boini KM and Li PL. Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice. Kidney Blood Press Res. 41:208-221, 2016.

Koka S, Aluri HS, Xi L, Lesnefsky EJ, Kukreja RC. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling. Am J Physiol Heart Circ Physiol, 306(11):H1558-68, 2014.

Das A, Durrant D, Koka S, Salloumn FN, Xi L, Kukreja RC. mTOR Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice: Potential Role of Attenuated Oxidative Stress and Altered Contractile Protein Expression. J Biol Chem, 289(7):4145-60, 2013.

Koka S, Das A, Salloumn F, Kukreja RC. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in Type 2 diabetic mice. Free Radic Biol Med, 60:80-8, 2013.

Koka S, Xi L, Kukreja RC. Chronic Treatment with Long Acting Phosphodiesterase-5 Inhibitor Tadalafil Alters Proteomic Changes Associated with Cytoskeletal Rearrangement and Redox Regulation in Type 2 Diabetic Hearts. Basic Res Cardiol. 107:1-14, 2012.

Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Exp Clin Cardiol. 16(4): e30-5, 2011.

Koka S, Das A, Zhu SG, Durrant D, Xi L, Kukreja RC. Long-acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-induced Cardiomyopathy without Interfering with Chemotherapeutic Effect. J Pharmacol Exp Ther. 334: 1023-30, 2010.

Koka S, Kukreja RC. Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor. Mol Cell Pharmacol. 2: 173-178, 2010.

Farthing CA, Farthing DE, Koka S, Larus T, Fakhry I, Xi L, Kukreja RC, Sica D and Gehr T. A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma J Chromatogr B Analyt Technol Biomed Life Sci. 878: 2891-5, 2010.

Föller M, Bobbala D, Koka S, Boini KM, Mahmud H, Kasinathan RS, Shumilina E, Amann K, Beranek G, Sausbier U, Ruth P, Sausbier M, Lang F, Huber SM. Functional significance of the intermediate conductance Ca2+-activated K+ channel for the short-term survival of injured erythrocytes. Pflugers Arch. 460: 1029-44, 2010.

Heise N, Palme D, Misovic M, Koka S, Rudner J, Lang F, Salih HR, Huber SM, Henke G. Non-selective cation channel-mediated Ca2+-entry and activation of Ca2+/calmodulin-dependent kinase II contribute to G2/M cell cycle arrest and survival of irradiated leukemia cells. Cell Physiol Biochem. 26: 597-608, 2010.

Ghashghaeinia M, Bobbala D, Wieder T, Koka S, Brück J, Fehrenbacher B, Rocken M, Schaller M, Lang F, Ghoreschi K. Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling. Am J Physiol Cell Physiol. 299: C791-804, 2010.

Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F. Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem. 23: 191-198, 2009.

Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S, Shumilina E, Kempe DS, Tanneur V, Akel A, Lang KS, Foller M, Kun JF, Kremsner PG, Wesselborg S, Laufer S, Clemen CS, Herr C, Noegel AA, Wieder T, Gulbins E, Lang F, Huber SM. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency Cell Physiol Biochem. 24: 415-28, 2009.

Bobbala D, Koka S, Geiger C, Foller M, Huber SM, Lang F. Azathioprine favourably influences the course of malaria. Malar J. 8: 102, 2009.

Föller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Münzel T, Lang F. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 23: 1072-80, 2009.

Föller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F. Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem. 24: 133-40, 2009.

Kempe DS, Ackermann TF, Fischer SS, Koka S, Boini KM, Mahmud H, Föller M, Rosenblatt KP, Kuro-O M, Lang F. Accelerated suicidal erythrocyte death in Klotho-deficient mice. Pflugers Arch. 458(3):503-12, 2009.

Boini KM, Graf D, Hennige AM, Koka S, Kempe DS, Wang K, Ackermann TF, Föller M, Vallon V, Pfeifer K, Schleicher E, Ullrich S, Häring HU, Häussinger D, Lang F. Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. Am J Physiol Regul Integr Comp Physiol. 296: R1695-701, 2009.

Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F. Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem. 22: 261-268, 2008. 

Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay J, Huber SM, Lang F.  Influence of NO synthase inhibition L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem. 21: 481-488, 2008.

Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy FM, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP,  Horn FL and Lerche H. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and a cation leak of this glucose transporter is linked to hemolytic anemia. J Clin Invest. 118(6):2157-68, 2008.

Duranton C, Tanneur V, Lang C, Brand VB, Koka S, Kasinathan RS, Dorsch M, Hedrich HJ, Baumeister S, Lingelbach K, Lang F, Huber SM. A high specificity and affinity interaction with serum albumin stimulates an anion conductance in malaria-infected erythrocytes. Cell Physiol Biochem. 22: 395-404, 2008.

Bobbala D, Koka S, Lang C, Boini KM, Huber SM, Lang F. Effect of cyclosporine on parasitemia and survival of Plasmodium berghei infected mice. Biochem Biophys Res Commun. 376: 494-8, 2008. 

Brand V, Koka S, Lang C, Jendrossek V, Huber SM, Gulbins E, Lang F. Influence of amitriptyline on eryptosis, parasitemia and survival of Plasmodium berghei-infected mice. Cell Physiol Biochem. 22: 405-12, 2008.

Föller M, Feil S, Ghoreschi K, Koka S, Hofmann F, Schuler B, Vogel J, Kasinathan RS, Nicolay JP, Huber SM, Lang F, Feil R. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci U S A 105: 6771-6, 2008.

Michael Föller, Ravi. S. Kasinathan, Saisudha Koka, Camelia Lang, Ekaterina Shumilina, Markus Freichel, Veit Flockerzi, Lutz Birnbaumer, Florian Lang, and Stephan M. Huber. TRPC6 contributes to the Ca2+ leak of human erythrocytes. Cell Physiol Biochem. 21: 183-192, 2008.

Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rübben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Häussinger D, Gulbins E, Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nature Medicine 13: 164-170, 2007. 

Koka S, Huber SM, Boini KM, Lang C, Foller M, Lang F.  Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice. Biochem Biophys Res Commun. 363: 484-489, 2007.

Koka S, Föller M, Lamprecht G, Boini KM, Lang C, Huber SM, Lang F. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem Biophys Res Commun. 357: 608-14, 2007.

Nicolay JP, Liebig G, Niemoeller OM, Koka S, Ghashghaeinia M, Wieder T, Haendeler J, Busse R, Lang F. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch. 456(2):293-305, 2007. 

Kasinathan RS, Föller M, Lang C, Koka S, Lang F, Huber SM. Oxidation induces ClC-3-dependent anion channels in human leukaemia cells. FEBS Lett. 581:  5407-5412, 2007.

Föller M, Mahmud H, Koka S, Lang F. Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice. Pflugers Arch. 455:  939-949, 2007. 

Föller M, Kasinathan RS, Koka S, Huber SM, Schuler B, Vogel J, Gassmann M, Lang F. Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin. Am J Physiol Regul Integr Comp Physiol. 293: R1127-34, 2007. 

Akel A, Wagner CA, Kovacikova J, Kasinathan RS, Kiedaisch V, Koka S, Alper SL, Bernhardt I, Wieder T, Huber SM, Lang F. Enhanced suicidal death of erythrocytes from gene-targeted mice lacking the Cl-/HCO(3)(-) exchanger AE1. Am J Physiol Cell Physiol. 292: C1759-67, 2007. 

Kasinathan RS, Föller M, Koka S, Huber SM, Lang F.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid. Naunyn Schmiedebergs Arch Pharmacol. 374: 255-64, 2007

Nammi S, Koka S, Chinnala KM, Boini KM. Obesity: An overview on its current perspectives and treatment options. Nutr J. 3: 3, 2004

Book Chapters

Koka S, Aluri HS, Xi L, Lesnefsky EJ and Kukreja RC. Phosphodiesterase-5 inhibition and Cardioprotection in Type 2 Diabetes: Role of Mitochondria. Adaptation Biology and Medicine: 2016©Narosa Publishing House Ltd (In Press)

Koka S and Kukreja RC. Phosphodiesterse-5 inhibitors in Protection of Diabetic Heart. Diabetic Cardiomyopathy: Advances in Boichemistry in Health and Disease, Volume 9, 323-338, 2014 ©Springer Science and Business Media Dordrecht LLC. USA. 

Koka S, Xi L and Kukreja RC. Phosphodiesterse-5 inhibition with Tadalafil attenuates detrimental proteomic changes in type 2 diabetic myocardium. Adaptation Biology and Medicine: New Challenges, Volume 7, 2014 ©Narosa Publishing House Ltd.

Koka S and Kukreja RC. Phosphodiesterse-5 inhibitors in Protection against Doxorubicin-Induced Cardiomyopathy. Molecular Defects in Cardiovascular Disease, Part 2, 243-255, 2011© Springer Science+Business Media, LLC.

Research Support

Type: Postdoctoral Fellowship
Source: American Heart Association, Mid-Atlantic Affiliate
Role: Principal Investigator
Title: Role of SIRT1 in PDE-5 inhibitor induced Cardioprotection in Diabetic Mice
Dates: : 07/1/2011 – 06/30/2013
Total Award: $82,000

Type: Stipend for research studies of International Scholars
Source: Deutscher Akademischer Austausch Dienst (DAAD) Stibet, Germany
Role: International graduate student scholar
Title:Suicidal Erythrocyte Death in Malaria
Dates: 09/1/2007 – 01/30/2008
Total Award: Euro 4,250

Type: Research Fellowship
Source: Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India
Role: Summer student fellow
Title: Biochemical and Genetic studies on 2, 4- DNP & PNP Degrading Bacteria
Dates: 05/31/2001 – 07/30/2001
Total Award: INR 8,000

Abstracts and Presentations

Koka S, Xia M, Chen Y, Li PL, Boini KM. Trimethylamine-N-Oxide, an Intestinal Microbial Metabolite Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction. FASEB J, 30, No.1 Supplement 1204.10, 2016

Koka S, Xia M, Conley SM, Gehr TW, Li N, Li PL, Boini KM. Adiponectin Protects Mouse Podocytes from Acid Ceramidase Inhibition-Induced Injury. FASEB J, 30:739.16, 2016

Boini KM, Xia M, Conley SM, Li G, Koka S, Gehr TW, Li PL. Contribution of High Mobility Group Box 1 to Hyperhomocysteinemia-induced Podocyte Injury and Glomerular Sclerosis. Hypertension 60: E107, 2015

Das A, Durrant D, Koka S, Salloum F, Xi L, Kukreja RC. Chronic Rapamycin Treatment improves Cardiac function by attenuating Oxidative Stress and altering contractile proteins in Type 2 Diabetic Mice. Circulation 128: A14020, 2013

Koka S, Aluri H, Lesnefsky EJ, Kukreja RC. Phosphodiesterase-5 (PDE-5) Inhibitor, Tadalafil, Activates NO/Sirt1/PGC-1α Signaling and Attenuates Mitochondrial Dysfunction in Type 2 Diabetic Hearts. Circulation 126: A11633, 2012

Das A, Salloum FN, Koka S, Xi L, Tian R, Kukreja RC. AMP-Activated Protein Kinase Plays an Essential Role in Sildenafil-Induced Cardioprotection against Ischemia-Reperfusion Injury. Circulation 126: A16498, 2012

Koka S, Xi L, Kukreja RC. Chronic Treatment with Tadalafil Protects against Diastolic Dysfunction and Ischemia/Reperfusion Injury in a Mouse Model of Metabolic Syndrome. Circulation 126: A11636, 2012

Aluri HS, Koka S, Lesnefsky, Kukreja RC. Chronic treatment with the long acting phosphodiesterase-5 inhibitor, tadalafil, decreases mitochondrial damage in diabetic mice. Mitochondrion 12:5-P576, 2012

Koka S, Das A, Salloum FN, Kukreja RC. Long acting Phosphodiesterase-5 inhibitor tadalafil protects against Myocardial Ischemia/ Reperfusion Injury in Type 2 Diabetic Mice via Suppression of Oxidative Stress and Akt-AMPk signaling. Winnipeg Heart International Conference-2011, Institute of Cardiovascular Sciences, Winnipeg, Canada, 2011

Koka S, Das A, Salloum FN, Kukreja RC. Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Oxidative Stress and Protects Against Myocardial Ischemia/Reperfusion Injury in Type 2 Diabetic Mice. Circulation 124:A17038, 2011

Das A, Durrant D, Salloum FN, Koka S, Kukreja RC. Chronic Treatment with Rapamycin Attenuates Diabetes-Associated Adverse Effects and Protects Against Myocardial Ischemia/Reperfusion Injury in Type II Diabetic Mice Circulation 124:A14373, 2011

Koka S, Salloum FN, Kukreja RC. Chronic Treatment with Long acting Phosphodiesterase-5 inhibitor tadalafil protects against Diastolic Dysfunction in Type 1 Diabetic Cardiomyopathy. Circulation 122:A16206. 2010

Koka S, Das A, Zhu SG, Durrant D, Xi L, Kukreja RC. Phosphodiesterase-5 Inhibitor with Tadalafil Attenuates Left Ventricular Dysfunction and Cardiomyocyte Apoptosis in Doxorubicin-induced Cardiotoxicity in Mice. FASEB J. 24: 785.10, 2010

Bobbala D, Koka S, Lang C, Boini KM, Huber S, Lang F. Effect of cyclosporine on parasitemia and survival of Plasmodium berghei-infected mice. Acta Physiologica 195: S669: P124, 2009

Föller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Münzel T, Lang F. Regulation of erythrocyte survival by AMP-activated protein kinase. Acta Physiologica 195: S669: P124, 2009

Alesutan A, Bobbala D, Koka S, Geiger C, Föller M, Huber S, Lang F. Azathioprine favorably influences the course of malaria. Acta Physiologica 195: S669: P125, 2009

Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay JP, Huber SM and Lang F. Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Acta Physiologica 192: S663:P171, March 2008

Huber SM, Föller M, Koka S, Boini KM, Shumilina E, Mahmud H, Ruth P, Sausbier M, Lang F. Functional significance of SK4 K+ channels for erythrocyte death. Acta Physiologica 192:S663:P54, March 2008

Lang C, Koka S, Boballa D, Lang F and Huber S. Plasmodium falciparum employs the CaMKII and PKCα of its host to alter the erythrocyte membrane permeability. Acta Physiologica 192: S663:P171, March 2008

Koka S, Föller M, Boini KM, Lang C, Huber SM and Lang F. Influence of iron deficiency on the course of malaria in Plasmodium berghei infected mice. Acta Physiologica 189: S653:P155, March 2007

Lang C, Koka S, Kasinathan RS, Lang F and Huber SM. Osmolyte channels in malaria-infected erythrocytes. Acta Physiologica 189: S653:P155, March 2007

Föller M, Kasinathan RS, Koka S, Lang F and Huber SM. PGE2-induced apoptotic cell death in K562 human leukaemia cells through activation of TRPC7 non-selective cation channels. Acta Physiologica 186: S1:P176, 2006

Koka S, Tanneur V, Kasinathan R, Lang F and Huber SM. Purinoceptor signalling during malaria infection. Acta Physiologica 186: S1:P269, 2006

Koka S. Human Cloning -oral presentation in the Dept. of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India during March 1-2, 2005

Koka S. Skeletal Fluorosis – A Crippling bone disease poster presentation in the International Convention of APTI -2004 Andhra University, Visakhapatnam, India during October 2-3, 2004

Koka S. SARS- World’s latest syndrome poster presentation in the National seminar on ‘Pharmaceutical Research: Present and Future perspectives’ Andhra University, Visakhapatnam, India during September 26-27, 2003

Koka S. Cox-2 inhibitors- A new therapeutic target – oral presentation in the Elysium-2001 – Golden Jubilee Celebrations, Andhra University, Visakhapatnam, India on March 30, 2001

Koka S. Current Approaches in Novel Drug Delivery Systems- oral presentation in National Conference of Pharmacy Students, Pharmacon-2000, Andhra University, Visakhapatnam, India during March 11-12, 2000

Invited Presentations

  • Principles of dosing in preclinical and clinical studies, Department of Pharmacology and toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, June 12, 2016
  • Pathophysiology and Pharmacology of beta blockers, Department of Pharmaceutical Sciences, College of Pharmacy, University of Findlay, Findlay, Ohio, August 13, 2015
  • Regulation of NO/SIRT1 signaling by PDE-5 Inhibitors: Therapeutic role in Cardiovascular and Metabolic disorders, Department of Family and Community Health Nursing, School of Nursing, Virginia Commonwealth University, Richmond, VA, June 23,2014
  • Novel Protective Strategies against Ischemia/Reperfusion Injury in diabetic hearts. Department of Pharmacology, School of medicine, Howard University, Washington DC, December 12, 2012

Professional Service & Affiliations

Memberships

  • American Heart Association
  • American Society of Pharmacological and Experimental Therapeutics
  • American Physiological Society
  • American Association of Pharmaceutical Scientists
  • Andhra Pradesh State Pharmacy Council
  • Indian Pharmaceutical Association 

Peer Reviewer

  • Scientific Reports, Nature, 2016-present
  • Journal of American Heart Association, 2016- present
  • Journal of Diabetes Research 2015- present
  • Kidney & Blood pressure research 2015-present
  • Nephron Physiology, 2015- present
  • Cellular Physiology and Biochemistry, 2013-present

Service Activities

  • International Scholar member, Task Force on Comprehensive Internationalization, VCU,  2013
  • Judge, Senior Division, Metro Richmond STEM Fair, March 23, 2013, Richmond, USA 2013
  • Member, Postdoctoral Advisory Committee, VCU, Richmond, USA, 2012
  • Judge, 5th Annual Center on Health Disparities Undergraduate Research Training Summer Symposium, Aug. 2-5, 2011, VCU, Richmond, USA, 2011
  • Member, Postdoctoral Advisory Committee, VCU, Richmond, USA, 2010
  • Co-Chair, International Committee, VCU Postdoctoral Association, 2010
  • Member, Executive Committee, VCU Postdoctoral Association, 2010
  • Coordinator, Graduate Alumni-Promotionfeier, Tuebingen, Germany, 2008
  • Delegate, International Convention of Association of Pharmacy Teachers of India-2004, Visakhapatnam, India, 2004
  • Member, Organizing Committee, ELYSIUM-2001, Golden Jubilee celebrations, Andhra University, Visakhapatnam, India, 2001
  • Student Coordinator, PHARMACON-2000, Andhra University, Visakhapatnam, 2000